Ro.co vs Telos Rx: Wegovy Pill vs Compounded GLP-1 Options
Quick verdict: Ro.co is the only mainstream platform here offering the FDA-approved Wegovy pill and a $39 online get-started option, while Telos Rx focuses on compounded semaglutide and tirzepatide from as low as $99 per month, subject to clinician review.
Ro.co vs Telos Rx: core differences at a glance
This comparison examines the most distinctive differences between Ro.co and Telos Rx using only the supplied facts: medication type and regulatory status, starting price and pricing model, medication options and formulation, and who each provider may suit best. The primary keyword Ro.co vs Telos Rx appears here to reflect search intent.
1. Medication type and regulatory status
Ro.co: Offers the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication. The source explicitly contrasts FDA-approved finished medication with compounded alternatives and notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Telos Rx: Prescribes compounded semaglutide and tirzepatide, both described as compounded medications and explicitly noted as not FDA-approved. Telos Rx states these compounded medications are prescription-only and prescribed only after review by a US-licensed provider.
2. Starting price and pricing model
Ro.co: The captured material repeatedly states you can get started online for just $39. Ongoing pricing depends on the treatment plan and medication prescribed, and branded medications like the Wegovy pill carry higher costs than compounded alternatives. Ro.co claims no hidden fees and pricing disclosed before consultation.
Telos Rx: Advertises compounded semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with examples listing higher numbers alongside the as-low-as pricing. Telos Rx also notes your price depends on your plan and that you may pay $0 if not approved. Cancel anytime, no penalties is stated for Telos Rx enrollment.
3. Medication options and formulations
Ro.co: Emphasizes access to the Wegovy pill, an oral semaglutide formulation offered as an FDA-approved finished medication and positioned as an injection-free option for patients who are injection-averse. The source frames this as a unique offering among mainstream platforms in the comparison set.
Telos Rx: Focuses on compounded injectable medications in two molecule classes: semaglutide (GLP-1) and tirzepatide (GLP-1 plus GIP). Telos Rx explains tirzepatide works on GLP-1 and GIP together and that a US-licensed provider decides which molecule is appropriate.
4. Clinical review and availability
Both providers require clinician review. Ro.co specifies treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx states semaglutide and tirzepatide are prescription-only and prescribed only after review by a US-licensed provider, and pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Comparison table
| Criteria | Ro.co | Telos Rx |
|---|---|---|
| Medication type | Wegovy pill, FDA-approved finished medication | Compounded semaglutide and tirzepatide |
| Regulatory note | FDA-approved for Wegovy pill; contrasts with compounded meds | Compounded medications not FDA-approved |
| Starting price | Get started online for just $39 | Semaglutide as low as $99 per month |
| Formulation | Oral GLP-1 pill | Compounded injectable GLP-1 and GLP-1 + GIP |
| Clinician review | Treatment only when a licensed clinician determines it is medically appropriate | Prescription-only after review by a US-licensed provider |
What the differences mean for patients
If FDA approval and an oral, injection-free option are priorities, the supplied evidence identifies Ro.co as the only mainstream platform in this set offering that path, plus a $39 online start. If lower as-start pricing for compounded semaglutide or access to tirzepatide as a dual-action molecule is the priority, Telos Rx advertises compounded semaglutide from as low as $99 per month and tirzepatide from as low as $139 per month, with clinician approval required.
Choose based on these supplied facts
- Choose Ro.co if you want access to the FDA-approved Wegovy pill, an oral GLP-1 option, and a $39 online starting entry, with pricing disclosed before consultation.
- Choose Telos Rx if you prioritize compounded semaglutide or tirzepatide with as-low-as monthly pricing from $99 for semaglutide or $139 for tirzepatide, and accept that these are compounded medications prescribed after a US-licensed provider review.
This comparison focused only on the supplied facts about Ro.co and Telos Rx. For people deciding between them, Ro.co vs Telos Rx highlights a trade-off between an FDA-approved oral medication and lower as-start compound pricing, subject to clinician review and the regulatory distinctions noted above.